Expression of transketolase-like 1 (TKTL1) and p-Akt correlates with the progression of cervical neoplasia

Journal of Obstetrics and Gynaecology Research

Volumn 34, Issue 3, 2008, Pages 293-300

  Kohrenhagen, Nico ^a   Voelker, Hans U ^a   Schmidt, Melanie ^a   Kapp, Michaela ^a   Krockenberger, Matthias ^a   Frambach, Torsten ^a   Dietl, Johanees ^a   Kammerer, Ulrike ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Cervical cancer; Immunohistochemistry; p Akt; Squamous neoplasia; Transketolase like enzyme 1 (TKTL1)

Indexed keywords

PROTEIN KINASE B; TRANSKETOLASE; TRANSKETOLASE LIKE ENZYME 1;

ARTICLE; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; GLYCOLYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; UTERINE CERVIX CANCER;

CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; FEMALE; GLYCOLYSIS; HUMANS; IMMUNOHISTOCHEMISTRY; PARAFFIN EMBEDDING; PROTO-ONCOGENE PROTEINS C-AKT; TRANSKETOLASE; UTERINE CERVICAL NEOPLASMS;

EID: 45149133965     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2008.00749.x     Document Type: Article

References (29)

1. Becker N, Wahrendorf J. Atlas of Cancer Mortality in the Federal Republic of Germany, 3rd edn. Heidelberg : Springer-Verlag, 2002.
2. Ackermann S, Beckmann MW, Altgassen C. Therapie des Zervixkarzinoms. Moderne operative Ansätze. Der Gynäkologe 2004 37 : 674 680.
3. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999 49 : 33 64.
4. Warburg O, Posener K, Negelein E. Über den Stoffwechsel der Karzinomzellen. Biochem Z 1924 152 : 309 344.
5. Rais B, Comin B, Puigianer J et al. Oxythiamine and dehydroepiandrosterone induce a G1 phase cycle arrest in Ehrlich and squamous tumor cells through inhibition of the pentose cycle. FEBS Lett 1999 456 : 113 118.
6. Mendez LE, Manci N, Guilherme C et al. Expression of glucose transporter-1 in cervical cancer and its precursors. Gynecol Oncol 2002 86 : 138 143.
7. Airley RE, Loncaster J, Raleigh JA et al. Glut-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: Relationship to pimonidazole binding. Int J Cancer 2003 104 : 85 91.
8. Ramanathan A, Wang C, Schreiber SL. Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements. Proc Natl Acad Sci USA 2005 102 : 5992 5997.
9. Langbein S, Zerilli M, zur Hausen A et al. Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted. Br J Cancer 2006 94 : 578 585.
10. Comin-Anduix B, Boren J, Martinez S et al. The effect of thiamine supplementation on tumour proliferation. A metabolic control analysis study. Eur J Biochem 2001 268 : 4177 4182.
11. Volker HU, Scheich M, Schmausser B, Kammerer U, Eck M. Overexpression of transketolase TKTL1 is associated with shorter survival in laryngeal squamous cell carcinomas. Eur Arch Otorhinolaryngol 2007 264 : 1431 1436.
12. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004 4 : 891 899.
13. Coy JF, Dressler D, Wilde J et al. Mutations in the transketolase-like gene TKTL1: Clinical implications for neurodegenerative diseases, diabetes and cancer. Clin Lab 2005 51 : 257 273.
14. Krockenberger M, Honig A, Rieger L et al. Transketolase-like 1 expression correlates with subtypes of ovarian cancer and the presence of distant metastases. Int J Gynecol Cancer 2007 17 : 101 106.
15. Zhang S, Yang JH et al. Gene silencing of TKTL1 by RNAi inhibits cell proliferation in human hepatoma cells. Cancer Lett 2007 253 : 108 114.
16. Hu LH, Yang JH, Zhang DT et al. The TKTL1 gene influences total transketolase activity and cell proliferation in human colon cancer LoVo cells. Anticancer Drugs 2007 18 : 427 433.
17. Sun M, Wang G, Paciga JE, Feldman RI. AKT1/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells. Am J Pathol 2001 159 : 431 437.
18. Elstrom RL, Bauer DE, Buzzai M et al. Akt stimulates aerobic glycolysis in cancer cells. Cancer Res 2004 64 : 3892 3899.
19. Barnes K, McIntosh E, Whetton AD, Daley GQ, Bentley J, Baldwin SA. Chronic myeloid leukaemia: An investigation into the role of Bcr-Abl-induced abnormalities in glucose transport regulation. Oncogene 2005 24 : 3257 3267.
20. Majewski N, Nogueira V, Bhaskar P et al. Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Mol Cell 2004 16 : 819 830.
21. Buzzai M, Bauer DE, Jones RG et al. The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation. Oncogene 2005 24 : 4165 4173.
22. Foldi M, Stickeler E, Bau L et al. Transketolase protein TKTL1 overexpression: A potential biomarker and therapeutic target in breast cancer. Oncol Rep 2007 17 : 841 845.
23. Fantin VR, St-Pierre J, Leder P. Attenuation of LDH-A expression uncovers a link between glyolysis, mitochondrial physiology and tumor maintenance. Cancer Cell 2006 9 : 425 434.
24. Williams AC, Collard TJ, Paraskeva C. An acidic environment leads to p53 dependent induction of apoptosis in human adenoma and carcinoma cell lines: Implications for clonal selection during colorectal carcinogenesis. Oncogene 1999 18 : 3199 3204.
25. Park HJ, Lyons JC, Ohtsubo T et al. Cell cycle progression and apoptosis after irradiation in an acidic environment. Cell Death Differ 2000 7 : 729 738.
26. Di Chiro G, Hatazawa J, Katz DA et al. Glucose utilization by intracranial meningeomas as an index of tumor aggressivity and probability of recurrence: A PET study. Radiology 1987 164 : 521 526.
27. Haberkorn U, Strauss LG, Reisser C et al. Glucose uptake, perfusion and cell proliferation in head and neck tumors: Relation of positron emission tomography to flow cytometry. J Nucl Med 1991 32 : 1555 1558.
28. Downey RJ, Akhurst T, Gonen M et al. Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. J Clin Oncol 2004 22 : 3255 3260.
29. Walenta S, Schrader T, Mueller-Kieser W. Lactate in solid malignant tumours: Potential basis of a metabolic classification in clinical oncology. Curr Med Chem 2004 11 : 2195 2204.